First Time Loading...
P

POINT Biopharma Global Inc
NASDAQ:PNT

Watchlist Manager
POINT Biopharma Global Inc
NASDAQ:PNT
Watchlist
Price: 12.5 USD Market Closed
Updated: May 5, 2024

Income Statement

Earnings Waterfall
POINT Biopharma Global Inc

Revenue
243.8m USD
Operating Expenses
-136m USD
Operating Income
107.8m USD
Other Expenses
-11.2m USD
Net Income
96.6m USD

Income Statement
POINT Biopharma Global Inc

Rotate your device to view
Income Statement
Currency: USD
Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023
Revenue
Revenue
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
227
N/A
236
+4%
241
+2%
244
+1%
Operating Income
Operating Expenses
(14)
(31)
(46)
(56)
(72)
(80)
(101)
(117)
(128)
(136)
Selling, General & Administrative
(3)
(7)
(12)
(14)
(17)
(16)
(19)
(20)
(21)
(23)
Research & Development
(11)
(24)
(34)
(42)
(56)
(64)
(82)
(96)
(107)
(113)
Operating Income
(14)
N/A
(31)
-118%
(46)
-45%
(56)
-23%
(72)
-29%
(80)
-11%
126
N/A
119
-5%
113
-6%
108
-4%
Pre-Tax Income
Interest Income Expense
0
0
(0)
0
1
1
4
10
14
19
Pre-Tax Income
(14)
N/A
(31)
-118%
(46)
-45%
(56)
-23%
(72)
-28%
(79)
-9%
130
N/A
129
0%
127
-1%
127
0%
Net Income
Tax Provision
(0)
(0)
(0)
(0)
(1)
(1)
(31)
(31)
(30)
(31)
Income from Continuing Operations
(15)
(32)
(46)
(57)
(72)
(79)
98
98
97
97
Net Income (Common)
(15)
N/A
(32)
-117%
(46)
-45%
(57)
-23%
(72)
-28%
(79)
-10%
98
N/A
98
0%
97
-1%
97
-1%
EPS (Diluted)
-0.16
N/A
-0.35
-119%
-0.62
-77%
-0.63
-2%
-0.8
-27%
-0.87
-9%
1.02
N/A
0.92
-10%
0.92
N/A
0.91
-1%

See Also

Discover More